Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation - Top-Institutions - MDSpire

Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation

  • By

  • Tugce Kutuk

  • Marshall Harrell

  • Kari Flaute

  • Christina Flores

  • Neha Rao

  • Regan Memmott

  • James Bradley Elder

  • Joshua Palmer

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Radiation Oncology

  • #3

    Centre Hospitalier Universitaire (CHU), Montpellier
    Centre Hospitalier Universitaire (CHU), Montpellier

    Montpellier, France

    Key Differentiators

    • Radiation Oncology

  • #4

    The Royal Marsden Hospital NHS Foundation Trust
    The Royal Marsden Hospital NHS Foundation Trust

    London, United Kingdom

    Key Differentiators

    • Radiation Oncology

  • #5

    Duke University School of Medicine
    Duke University School of Medicine

    Durham, North Carolina

    Key Differentiators

    • Radiation Oncology

Original Source(s)

Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation

  • by Tugce Kutuk, Marshall Harrell, Kari Flaute, Christina Flores, Neha Rao, Regan Memmott, James Bradley Elder, Joshua Palmer

  • July 14, 2026

Related Content

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations

What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis

Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis